Hillsdale Investment Management Inc. Boosts Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Hillsdale Investment Management Inc. raised its stake in Balchem Co. (NASDAQ:BCPC) by 0.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,440 shares of the basic materials company’s stock after acquiring an additional 200 shares during the period. Hillsdale Investment Management Inc. owned approximately 0.07% of Balchem worth $3,658,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Westside Investment Management Inc. bought a new stake in shares of Balchem in the third quarter worth about $27,000. R Squared Ltd bought a new stake in Balchem in the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Balchem during the 3rd quarter worth approximately $35,000. Venturi Wealth Management LLC bought a new position in shares of Balchem during the 4th quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock valued at $106,000 after purchasing an additional 450 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on BCPC. HC Wainwright reaffirmed a “buy” rating and set a $190.00 price target on shares of Balchem in a research note on Monday, February 24th. Sidoti upgraded shares of Balchem to a “hold” rating in a research report on Tuesday, February 25th. Finally, StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th.

Balchem Stock Performance

NASDAQ:BCPC opened at $161.17 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The stock’s fifty day moving average is $164.71 and its 200 day moving average is $169.42. The firm has a market capitalization of $5.24 billion, a PE ratio of 41.01, a PEG ratio of 4.41 and a beta of 0.63. Balchem Co. has a fifty-two week low of $137.69 and a fifty-two week high of $186.03.

Balchem (NASDAQ:BCPC) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, sell-side analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.